Management of psoriasis vulgaris and multiple sclerosis with fumaric acid - 14/02/14
Doi : 10.1016/j.jaad.2013.10.031
Spyridon Gkalpakiotis, MD, PhD a, ⁎ 
, Petr Arenberger, MD, PhD, DSc, Prof a, Petra Gkalpakioti, MD a, Eva Meluzinova, MD b, Devika Chandran, MD a, Monika Arenbergerova, MD, PhD a
, Petr Arenberger, MD, PhD, DSc, Prof a, Petra Gkalpakioti, MD a, Eva Meluzinova, MD b, Devika Chandran, MD a, Monika Arenbergerova, MD, PhD a a Department of Dermatovenereology, Third Faculty of Medicine, Charles University in Prague and University Hospital of Kralovske Vinohrady, Prague, Czech Republic
b Department of Neurology, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
∗Correspondence to: Spyridon Gkalpakiotis, MD, PhD, Assistant Professor, Department of Dermatovenereology, Third Faculty of Medicine, Charles University Prague, Srobarova 50, 100 34 Prague 10, Czech Republic
| Funding sources: This work was supported by research project P 27/2012, Charles University, Third faculty of Medicine in Prague. |
|
| Conflicts of interest: None declared. |
© 2013
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 70 - N° 3
P. e60-e61 - mars 2014 Retour au numéro
Article précédent
- Reactivation of herpes simplex virus infection in a patient undergoing ruxolitinib treatment
- Lana X. Tong, Julie Jackson, Justin Kerstetter, Scott D. Worswick
- Hemagglutination during photopheresis
- Lisa Mask-Bull, Sunaina B. Likhari, John A. Zic, John P. Greer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?